Turn Therapeutics TTRX
NASDAQ TTRX
$10.46 -0.01 (-0.10%)
As of: Oct 21, 2026 · 10:06 AM EDT

Turn Therapeutics (TTRX) Debt Ratio (2026)

Updated

Turn Therapeutics' Debt Ratio was 0.36 in Q2 2026, up 12.3% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Debt Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 0.39
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 0.24
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 0.52
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 0.42
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 0.53
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 0.31
10 Turn Therapeutics 311.58 Mn 284.69 Mn - 0.36
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.36
Mar 31, 2026 0.32
API Access

Turn Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TTRX&period=max&api_key=YOUR_API_KEY